Community/Retail

This marks omalizumab’s fourth FDA-approved indication for allergic and inflammatory conditions, such as severe persistent allergic asthma, with its initial approval being in 2003.

Children with heart disease who received infant open-heart surgery had more stress and neurodevelopmental impairments compared with children who did not undergo surgery.

Pharmacists can host community events and try different marketing efforts to drive community awareness about heart health and total health.

Taking a few seconds to double-check a prescription can have significant impacts on patient safety

With a wide array of OTC products, pharmacists can help patients select the right regimen

One significant difference was an increased rate of bupropion prescriptions for transgender females.

This episode highlights strategies for pharmacists and pharmacies to address social determinants of health barriers through leveraging PQA's SDOH Resource Guide.

Since the first FDA biosimilar approval of filgrastim-sndz (Zarxio) in 2015, a total of 44 biosimilars for 15 originator products have been approved and more than 20 are marketed.

Finding simple solutions to improve movement during the day can make important differences to their overall health

Nabila Ismail, PharmD, shares her journey as a travel and lifestyle creator

Nutrition is foundational to health, but healthy eating does not look the same for everyone.

This episode provides a brief overview of California's new Stop Dangerous Pharmacies Act, the benefits of e-prescribing for improving patient safety and outcomes, and New Jersey's pilot program for anonymous dispensing of opioid antidotes from pharmacies.

Iloprost had also received Priority Review and Orphan Drug Designations for this indication, and FDA approval in 2004 for the treatment of pulmonary arterial hypertension.

Researchers will continue to research how lantibiotic’s antimicrobial effects can be harnessed for good.

Continued doses of denosumab reduced the incidence of diabetes by more than 1000 patients compared to an initial dose alone.

Despite the growth in vaccine and antibody development for combatting RSV, lower income countries may not reap the benefits.

In this model, community pharmacists deliver all aspects of treating HCV infection in individuals who inject drugs.

This accreditation allows pharmacists to give diabetes education to patients with Medicare and receive Medicare reimbursement.

Black History Month provides a reminder of the systemic barriers facing many Americans

Mouthwash that contains chlorhexidine gluconate was especially effective at improving hyperglycemic status in younger patients with diabetes.

The findings suggest that 6 months after vaccination with ARCT-154, individuals had a longer immune response.

Cardiac Solutions, a physician-owned practice specializing in personalized treatment plans, used RevUp Remote Patient Monitoring and Chronic Care Management to achieve these cardiovascular readmission rates.

If approved, this would mark the first MDMA-assisted therapy and psychedelic-assisted therapy approved, calling for a reschedule of MDMA from Schedule I. A PDUFA was set for this summer.

Pharmacists are uniquely positioned to play a frontline role in advancing health equity. This will require, however, that we build the pipeline of future pharmacists and preserve vital community touchpoints.

Fouad Atouf, senior vice president of global biologics at US Pharmacopeia, discusses how established quality standards, drawing from the realm of small molecule drugs and evolving to meet the complexities of biologics, play a pivotal role in fostering trust.

Up-front payments to pharmacies will be significantly lower starting this year, creating cash flow challenges

The updated indication for the respiratory syncytial virus vaccine is for adults aged 50 to 59 with underlying conditions who are at an increased risk of contracting the virus.

The vitamin improved lipid metabolism to slow the progression of the disease.

Bepirovirsen is a triple action investigational antisense oligonucleotide and is being evaluated in the B-Well phase 3 clinical trial program for the treatment of chronic hepatitis B.